10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Scopus BioPharma has a beta of -0.21, meaning that its share price is 121% ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Amid more drug-price scrutiny, biopharma companies largely keep their January hikes in check By Kevin Dunleavy Jan 29, 2025 9:01am Drug Prices Pfizer Collegium Pharmaceutical Novartis ...

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno ...

Here, we highlight the trends and key deals. The transactions analysed include those in the biopharma industry, as well as consumer and over-the-counter companies, drug delivery technologies ...

GeekWire’s startup coverage documents the Pacific Northwest entrepreneurial scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and venture capital ...

Morgan Stanley estimates that around $175 billion of 2025 U.S. large-cap biopharma revenue – 35% of the total – will go off patent by the end of the decade. To replace that revenue drugmakers ...

A case can be made that metabolic medicine was the theme of the life sciences industry in 2024. Insatiable market demand fueled rocketing revenue growth for Novo Nordisk, which makes Wegovy, and ...